Analysis of two poor prognosis subgroups in ACIS evaluating apalutamide + abiraterone acetate plus prednisone (APA + AAP) versus placebo (PBO) + AAP in metastatic castration-resistant prostate cancer (mCRPC).

Fred  Saad

Honoraria - Abbvie; Astellas Pharma; AstraZeneca; Bayer; Janssen Oncology; Myovant Sciences; Pfizer; Sanofi

Consulting or Advisory Role - Abbvie; Astellas Pharma; AstraZeneca/MedImmune; Bayer; Janssen Oncology; Myovant Sciences; Pfizer; Sanofi

Research Funding - Astellas Pharma (Inst); AstraZeneca (Inst); Bayer (Inst); Bristol-Myers Squibb (Inst); Janssen Oncology (Inst); Pfizer (Inst); Sanofi (Inst)

Eleni  Efstathiou

Honoraria - Astellas Pharma; Janssen

Consulting or Advisory Role - Astellas Pharma; AstraZeneca; Bayer; Janssen; Merck; Myovant Sciences; ORIC Pharmaceuticals; Pfizer; Sanofi

Gerhardt  Attard

Honoraria - Astellas Pharma; Janssen; Janssen (I)

Consulting or Advisory Role - Abbott Laboratories; Astellas Pharma; AstraZeneca; Bayer; ESSA; Ferring; Janssen-Cilag; Medivation; Millennium; Novartis; Pfizer; Ventana Medical Systems; Veridex

Speakers' Bureau - Astellas Pharma; AstraZeneca; Ferring; Ipsen; Janssen; Sanofi; Takeda; Ventana Medical Systems

Research Funding - Arno Therapeutics (Inst); Innocrin Pharma (Inst); Janssen (Inst)

Patents, Royalties, Other Intellectual Property - I am on The ICR rewards to inventors list of abiraterone acetate.

Travel, Accommodations, Expenses - Abbott Laboratories; Astellas Pharma; Astellas Pharma (I); Bayer; ESSA; Ferring; Janssen; Janssen (I); Medivation; Pfizer; Ventana Medical Systems

Other Relationship - Institute of Cancer Research

Thomas W.  Flaig

Leadership - Aurora Oncology

Stock and Other Ownership Interests  - Aurora Oncology

Consulting or Advisory Role - Janssen Oncology; Seagen

Research Funding - Agensys; Aragon Pharmaceuticals; Astellas Pharma; astrazeneca/MedImmune; Bavarian Nordic; Bristol-Myers Squibb; Dendreon; Exelixis; GTx; Janssen Oncology; La Roche-Posay; Lilly; Medivation; Merck; Novartis; Pfizer; Roche/Genentech; Sanofi; Seagen; Seagen; Sotio; Tokai Pharmaceuticals

Patents, Royalties, Other Intellectual Property - The University of Colorado has filed 2 patents related in which I am an inventor. These are related to early-stage bladder cancer treatment and detection. Neither is commercialized or licensed at this time.

Fabio  Franke

No Relationships to Disclose

Oscar  Goodman

No Relationships to Disclose

Stephane  Oudard

Honoraria - Astellas Pharma; Bayer; Bristol-Myers Squibb; Eisai; IPSEN; Janssen; Merck; MSD; Novartis; Pfizer; Roche/Genentech; Sanofi

Consulting or Advisory Role - Astellas Pharma; Bayer; Boehringer Ingelheim; Bristol-Myers Squibb; Eisai; IPSEN; Janssen; Merck; MSD Oncology; MSD Oncology; Novartis; Pfizer; Roche; Roche; Sanofi

Research Funding - Ipsen; Sanofi

Travel, Accommodations, Expenses - Bayer; Boehringer Ingelheim; Bristol-Myers Squibb; Eisai; Merck; MSD Oncology; Novartis; Pfizer; Roche

Thomas  Steuber

Honoraria - Astellas Oncology; Bayer Health; Janssen; Sanofi

Consulting or Advisory Role - Astellas Oncology; Bayer Health; Janssen; Sanofi

Travel, Accommodations, Expenses - Astellas Oncology; Bayer Health; Janssen; Sanofi

Hiroyoshi  Suzuki

Honoraria - Daiichi Sankyo

Consulting or Advisory Role - Astellas Pharma; AstraZeneca; Bayer Health; Bayer Yakuhin; Janssen Research & Development; Lilly; MSD K.K; Nihon Medi-Physics; Roche; Sanofi

Speakers' Bureau - Astellas Pharma; Astellas Pharma; AstraZeneca; Bayer Yakuhin; Sanofi; Takeda

Research Funding - Bayer Yakuhin (Inst); Chugai Pharma (Inst); Daiichi Sankyo (Inst); Kissei Pharmaceutical (Inst); Nihonkayaku (Inst); Nippon Shinyaku (Inst); Ono Yakuhin (Inst); Taiho Pharmaceutical (Inst); Takeda (Inst)

Christopher Michael  Pieczonka

Employment - Associated Medical Professionals of New York

Leadership - Associated Medical Professionals of New York

Stock and Other Ownership Interests  - US Urology Partners

Honoraria - AstraZeneca; Bayer; Bristol-Myers Squibb; Dendreon; Janssen; Merck; Myovant Sciences; Pfizer/Astellas; Sun Pharma; Tolmar

Consulting or Advisory Role - AstraZeneca; Bayer; Bristol-Myers Squibb; Dendreon; Janssen Oncology; Merck; Pfizer/Astellas; Sun Pharma; Sun Pharma; Tolmar

Speakers' Bureau - Astellas Pharma; Bayer; Dendreon; Janssen Oncology; Merck; Myovant Sciences; Pfizer; Sun Pharma; Tolmar

Research Funding - Advantagene; Astellas Pharma; AstraZeneca; Bayer; Dendreon; Innocrin Pharma; Janssen Oncology; Merck; Pfizer

Francis  Parnis

Consulting or Advisory Role - Ipsen; Janssen Oncology; Merck Serono

Daphne  Wu

Employment - Janssen

Stock and Other Ownership Interests  - Johnson & Johnson

Kesav  Yeruva

Employment - Janssen

Stock and Other Ownership Interests  - Johnson & Johnson

Peter  De Porre

Employment - Johnson&Johnson

Stock and Other Ownership Interests  - Johnson&Johnson

Sabine Doris  Brookman-May

Employment - Janssen Research & Development

Leadership - Janssen Research & Development

Stock and Other Ownership Interests  - Johnson & Johnson

Susan  Li

Employment - Janssen

Stock and Other Ownership Interests  - Johnson & Johnson

Jinhui  Li

Employment - Janssen

Stock and Other Ownership Interests  - Johnson & Johnson

Suneel  Mundle

Employment - Janssen

Stock and Other Ownership Interests  - Johnson & Johnson

Sharon Anne  McCarthy

Employment - Janssen Oncology

Stock and Other Ownership Interests  - Johnson and Johnson

Dana E.  Rathkopf

Consulting or Advisory Role - AstraZeneca; Bayer; Genentech; Janssen; Myovant Sciences

Research Funding - AstraZeneca (Inst); Bayer (Inst); Celgene (Inst); Ferring (Inst); Genentech/Roche (Inst); Janssen Oncology (Inst); Medivation (Inst); Millennium (Inst); Novartis (Inst); Phosplatin Therapeutics (Inst); Taiho Pharmaceutical (Inst); Takeda (Inst); TRACON Pharma (Inst)